Michiyo Mochizuki

This inventor holds 11 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2011-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michiyo Mochizuki. Retrieved from https://idiyas.com/inventor/michiyo-mochizuki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 7)

% Patents Active = 54.5

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 7.7

ph-index = 4

Forward Citations = 74(Granted Patents)

Location History:

Osaka, JP (2011 - 2014)
Kanagawa, JP (2013 - 2022)
Fujisawa Kanagawa, JP (2021 - 2023)

Company Filing History:

11 out of 1,226

Takeda Pharmaceutical Company Limited

patents

Years Active: 2011-2024

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12171777 - Methods of making a cyclic dinucleotide (2024-12-24),

2. 11666594 - Antibody-drug conjugates comprising a cyclic dinucleotide (2023-06-06),

3. 11279713 - Heterocyclic compound and use thereof (2022-03-22),

4. 10980825 - Cyclic dinucleotide (2021-04-20),

5. 8901141 - Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them (2014-12-02),

6. 8785460 - Tricyclic compounds and use thereof (2014-07-22),

7. 8778934 - Heterocyclic compound and use thereof (2014-07-15),

8. 8575154 - Heterocyclic compound and use thereof (2013-11-05),

9. 8163935 - Fused heterocyclic compounds (2012-04-24),

10. 8039500 - Fused heterocyclic compounds (2011-10-18),

11. 7897607 - Cyclic compounds (2011-03-01),

Title: Michiyo Mochizuki: Innovator in Cyclic Dinucleotide Development

Introduction

Michiyo Mochizuki is a prominent inventor based in Fujisawa, Kanagawa, Japan. He is affiliated with Takeda Pharmaceutical Company Limited, where he has made significant contributions to the field of pharmaceutical innovation. With one patent to his name, he has demonstrated dedication to the advancement of medical science.

Latest Patents

Mochizuki is credited with a patent titled "Methods of making a cyclic dinucleotide." This patent describes a compound that exhibits STING (Stimulator of Interferon Genes) agonistic activity, which holds promise for the development of therapies aimed at preventing or treating STING-related diseases. The patent outlines a compound represented by a specific formula, as detailed in the patent description, or its salt forms.

Career Highlights

Throughout his career at Takeda Pharmaceutical Company Limited, Mochizuki has worked on groundbreaking research that bridges the gap between innovative biological compounds and therapeutic applications. His expertise in pharmaceutical development has played a vital role in propelling the company’s research initiatives forward.

Collaborations

Mochizuki collaborates closely with esteemed colleagues such as Masato Yoshikawa and Morihisa Saitoh. Their collective efforts in research and development have fostered advancements in the understanding of cyclic dinucleotides and their potential therapeutic benefits.

Conclusion

Michiyo Mochizuki's contributions to the field of pharmaceuticals through his innovative patent highlight the importance of research in addressing modern medical challenges. His dedication to developing new therapeutic agents reflects a commitment to improving health outcomes and advancing scientific knowledge in the industry.

Profile summary based on public USPTO records.